ResearcherChina Medical UniversityActive in the last 2 years
Fu-Ying Zhao
Matched on OpenAlex author ID A5053123185. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 3
- Lomitapide mesylate and lomitapide target ALDOA to inhibit growth and enhance gemcitabine efficacy in PDAC. First author DOI 10.1016/j.isci.2026.115316↗
- O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to glucose deficiency. Co-author DOI 10.1007/s13402-023-00915-5↗
- TRIM29 alters bioenergetics of pancreatic cancer cells via cooperation of miR-2355-3p and DDX3X recruitment to AK4 transcript. Co-author DOI 10.1016/j.omtn.2021.01.027↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hua‐Qin Wang · 2 shared papers, 2021–2024 · strength 0.37
- Paper O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to gluco… DOI 10.1007/s13402-023-00915-5↗
- Paper TRIM29 alters bioenergetics of pancreatic cancer cells via cooperation of miR-2355-3p and DDX3X recruitment to AK4 tran… DOI 10.1016/j.omtn.2021.01.027↗
- Huaqin Wang · 1 shared paper, 2026 · strength 0.33
- Yanjie Liu · 1 shared paper, 2026 · strength 0.33
- Jia Teng Sun · 1 shared paper, 2024 · strength 0.24
- Liang Hao · 1 shared paper, 2021 · strength 0.13
- Chao Li · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.